Global and United States Recombinant Protein Vaccine Market Report & Forecast 2024-2031

Report ID: 1829469 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Recombinant Protein Vaccine Product Introduction
    1.2 Global Recombinant Protein Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Recombinant Protein Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Recombinant Protein Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States Recombinant Protein Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Recombinant Protein Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Recombinant Protein Vaccine Sales in Volume for the Year 2017-2028
    1.4 Recombinant Protein Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Recombinant Protein Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Recombinant Protein Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Recombinant Protein Vaccine Market Dynamics
        1.5.1 Recombinant Protein Vaccine Industry Trends
        1.5.2 Recombinant Protein Vaccine Market Drivers
        1.5.3 Recombinant Protein Vaccine Market Challenges
        1.5.4 Recombinant Protein Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Recombinant Protein Vaccine Market Segment by Type
        2.1.1 Bacterial Cells Culture
        2.1.2 Mammalian Cells Culture
    2.2 Global Recombinant Protein Vaccine Market Size by Type
        2.2.1 Global Recombinant Protein Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Recombinant Protein Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Recombinant Protein Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Recombinant Protein Vaccine Market Size by Type
        2.3.1 United States Recombinant Protein Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Recombinant Protein Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Recombinant Protein Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Recombinant Protein Vaccine Market Segment by Application
        3.1.1 Human
        3.1.2 Animal
    3.2 Global Recombinant Protein Vaccine Market Size by Application
        3.2.1 Global Recombinant Protein Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Recombinant Protein Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Recombinant Protein Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Recombinant Protein Vaccine Market Size by Application
        3.3.1 United States Recombinant Protein Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Recombinant Protein Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Recombinant Protein Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Protein Vaccine Competitor Landscape by Company
    4.1 Global Recombinant Protein Vaccine Market Size by Company
        4.1.1 Top Global Recombinant Protein Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Recombinant Protein Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Recombinant Protein Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global Recombinant Protein Vaccine Price by Manufacturer (2017-2022)
    4.2 Global Recombinant Protein Vaccine Concentration Ratio (CR)
        4.2.1 Recombinant Protein Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Protein Vaccine in 2021
        4.2.3 Global Recombinant Protein Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Recombinant Protein Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global Recombinant Protein Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Recombinant Protein Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into Recombinant Protein Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Recombinant Protein Vaccine Market Size by Company
        4.5.1 Top Recombinant Protein Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Recombinant Protein Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Recombinant Protein Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Protein Vaccine Market Size by Region
    5.1 Global Recombinant Protein Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Recombinant Protein Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Recombinant Protein Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global Recombinant Protein Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Recombinant Protein Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global Recombinant Protein Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global Recombinant Protein Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Recombinant Protein Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Recombinant Protein Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Recombinant Protein Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Recombinant Protein Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Recombinant Protein Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Recombinant Protein Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Recombinant Protein Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Recombinant Protein Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Recombinant Protein Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Recombinant Protein Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck
        7.1.1 Merck Corporation Information
        7.1.2 Merck Description and Business Overview
        7.1.3 Merck Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Merck Recombinant Protein Vaccine Products Offered
        7.1.5 Merck Recent Development
    7.2 GSK
        7.2.1 GSK Corporation Information
        7.2.2 GSK Description and Business Overview
        7.2.3 GSK Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GSK Recombinant Protein Vaccine Products Offered
        7.2.5 GSK Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Corporation Information
        7.3.2 Sanofi Description and Business Overview
        7.3.3 Sanofi Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sanofi Recombinant Protein Vaccine Products Offered
        7.3.5 Sanofi Recent Development
    7.4 Zoties
        7.4.1 Zoties Corporation Information
        7.4.2 Zoties Description and Business Overview
        7.4.3 Zoties Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Zoties Recombinant Protein Vaccine Products Offered
        7.4.5 Zoties Recent Development
    7.5 Elanco
        7.5.1 Elanco Corporation Information
        7.5.2 Elanco Description and Business Overview
        7.5.3 Elanco Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Elanco Recombinant Protein Vaccine Products Offered
        7.5.5 Elanco Recent Development
    7.6 Boehringer-Ingelheim
        7.6.1 Boehringer-Ingelheim Corporation Information
        7.6.2 Boehringer-Ingelheim Description and Business Overview
        7.6.3 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Boehringer-Ingelheim Recombinant Protein Vaccine Products Offered
        7.6.5 Boehringer-Ingelheim Recent Development
    7.7 Indian Immunologicals
        7.7.1 Indian Immunologicals Corporation Information
        7.7.2 Indian Immunologicals Description and Business Overview
        7.7.3 Indian Immunologicals Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Indian Immunologicals Recombinant Protein Vaccine Products Offered
        7.7.5 Indian Immunologicals Recent Development
    7.8 Plumbline Life Sciences
        7.8.1 Plumbline Life Sciences Corporation Information
        7.8.2 Plumbline Life Sciences Description and Business Overview
        7.8.3 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Plumbline Life Sciences Recombinant Protein Vaccine Products Offered
        7.8.5 Plumbline Life Sciences Recent Development
    7.9 Novavax
        7.9.1 Novavax Corporation Information
        7.9.2 Novavax Description and Business Overview
        7.9.3 Novavax Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Novavax Recombinant Protein Vaccine Products Offered
        7.9.5 Novavax Recent Development
    7.10 Medicago
        7.10.1 Medicago Corporation Information
        7.10.2 Medicago Description and Business Overview
        7.10.3 Medicago Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Medicago Recombinant Protein Vaccine Products Offered
        7.10.5 Medicago Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Recombinant Protein Vaccine Industry Chain Analysis
    8.2 Recombinant Protein Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Recombinant Protein Vaccine Distributors
    8.3 Recombinant Protein Vaccine Production Mode & Process
    8.4 Recombinant Protein Vaccine Sales and Marketing
        8.4.1 Recombinant Protein Vaccine Sales Channels
        8.4.2 Recombinant Protein Vaccine Distributors
    8.5 Recombinant Protein Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Recombinant Protein Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Recombinant Protein Vaccine Market Trends
    Table 3. Recombinant Protein Vaccine Market Drivers
    Table 4. Recombinant Protein Vaccine Market Challenges
    Table 5. Recombinant Protein Vaccine Market Restraints
    Table 6. Global Recombinant Protein Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Protein Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Protein Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Protein Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Protein Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Protein Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Recombinant Protein Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Recombinant Protein Vaccine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Recombinant Protein Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Recombinant Protein Vaccine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Recombinant Protein Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Recombinant Protein Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Vaccine as of 2021)
    Table 18. Top Players of Recombinant Protein Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Recombinant Protein Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Recombinant Protein Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Recombinant Protein Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Recombinant Protein Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Recombinant Protein Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Recombinant Protein Vaccine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Recombinant Protein Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Recombinant Protein Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Recombinant Protein Vaccine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Recombinant Protein Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Recombinant Protein Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Protein Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Recombinant Protein Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Recombinant Protein Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Recombinant Protein Vaccine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Recombinant Protein Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Recombinant Protein Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Recombinant Protein Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Recombinant Protein Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Recombinant Protein Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Recombinant Protein Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Recombinant Protein Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck Corporation Information
    Table 43. Merck Description and Business Overview
    Table 44. Merck Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Merck Recombinant Protein Vaccine Product
    Table 46. Merck Recent Development
    Table 47. GSK Corporation Information
    Table 48. GSK Description and Business Overview
    Table 49. GSK Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. GSK Product
    Table 51. GSK Recent Development
    Table 52. Sanofi Corporation Information
    Table 53. Sanofi Description and Business Overview
    Table 54. Sanofi Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Sanofi Product
    Table 56. Sanofi Recent Development
    Table 57. Zoties Corporation Information
    Table 58. Zoties Description and Business Overview
    Table 59. Zoties Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Zoties Product
    Table 61. Zoties Recent Development
    Table 62. Elanco Corporation Information
    Table 63. Elanco Description and Business Overview
    Table 64. Elanco Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Elanco Product
    Table 66. Elanco Recent Development
    Table 67. Boehringer-Ingelheim Corporation Information
    Table 68. Boehringer-Ingelheim Description and Business Overview
    Table 69. Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Boehringer-Ingelheim Product
    Table 71. Boehringer-Ingelheim Recent Development
    Table 72. Indian Immunologicals Corporation Information
    Table 73. Indian Immunologicals Description and Business Overview
    Table 74. Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Indian Immunologicals Product
    Table 76. Indian Immunologicals Recent Development
    Table 77. Plumbline Life Sciences Corporation Information
    Table 78. Plumbline Life Sciences Description and Business Overview
    Table 79. Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Plumbline Life Sciences Product
    Table 81. Plumbline Life Sciences Recent Development
    Table 82. Novavax Corporation Information
    Table 83. Novavax Description and Business Overview
    Table 84. Novavax Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Novavax Product
    Table 86. Novavax Recent Development
    Table 87. Medicago Corporation Information
    Table 88. Medicago Description and Business Overview
    Table 89. Medicago Recombinant Protein Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Medicago Product
    Table 91. Medicago Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Recombinant Protein Vaccine Customers List
    Table 95. Recombinant Protein Vaccine Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Protein Vaccine Product Picture
    Figure 2. Global Recombinant Protein Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Protein Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Recombinant Protein Vaccine Sales 2017-2028 (K Units)
    Figure 5. United States Recombinant Protein Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Recombinant Protein Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Recombinant Protein Vaccine Sales 2017-2028 (K Units)
    Figure 8. United States Recombinant Protein Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Recombinant Protein Vaccine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Recombinant Protein Vaccine Report Years Considered
    Figure 11. Product Picture of Bacterial Cells Culture
    Figure 12. Product Picture of Mammalian Cells Culture
    Figure 13. Global Recombinant Protein Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global Recombinant Protein Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Recombinant Protein Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Recombinant Protein Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Recombinant Protein Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Recombinant Protein Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Recombinant Protein Vaccine Market Share by Type in 2022 & 2028
    Figure 20. United States Recombinant Protein Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Recombinant Protein Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Recombinant Protein Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Recombinant Protein Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Recombinant Protein Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Human
    Figure 26. Product Picture of Animal
    Figure 27. Global Recombinant Protein Vaccine Market Share by Application in 2022 & 2028
    Figure 28. Global Recombinant Protein Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Recombinant Protein Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Recombinant Protein Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Recombinant Protein Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Recombinant Protein Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Recombinant Protein Vaccine Market Share by Application in 2022 & 2028
    Figure 34. United States Recombinant Protein Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Recombinant Protein Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Recombinant Protein Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Recombinant Protein Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Recombinant Protein Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Recombinant Protein Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Recombinant Protein Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Recombinant Protein Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Recombinant Protein Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Recombinant Protein Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Recombinant Protein Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Recombinant Protein Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Recombinant Protein Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Recombinant Protein Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Recombinant Protein Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Recombinant Protein Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Recombinant Protein Vaccine Value Chain
    Figure 73. Recombinant Protein Vaccine Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Novavax
Medicago
Frequently Asked Questions
Recombinant Protein Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Protein Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Protein Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Genetic Vaccine

Genetic Vaccine market is segmented by region (country), players, by Type and by Application. Pla ... Read More